Ado-trastuzumab emtansine and Insulin glulisine Subcutaneous
Determining the interaction of Ado-trastuzumab emtansine and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Insulin human inhaled Inhalation
- Ado-trastuzumab emtansine-Insulin human regular Injection
- Ado-trastuzumab emtansine-Insulin inhalation
- Ado-trastuzumab emtansine-Insulin isophane
- Ado-trastuzumab emtansine-Insulin isophane and insulin regular
- Ado-trastuzumab emtansine-Insulin lispro
- Insulin glulisine Subcutaneous-Ado-trastuzumab emtansine Intravenous
- Insulin glulisine Subcutaneous-Adox Pak 2/100
- Insulin glulisine Subcutaneous-Adoxa
- Insulin glulisine Subcutaneous-Adoxa CK
- Insulin glulisine Subcutaneous-Adoxa Pak
- Insulin glulisine Subcutaneous-Adoxa Pak 1/100